In Pursuit of an Allosteric Human Tropomyosin Kinase A (hTrkA) Inhibitor for Chronic Pain
Author:
Affiliation:
1. Veterinary Medicine Research & Development, Zoetis, 333 Portage Street, Building 300, Kalamazoo, Michigan 49007, United States
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.1c00483
Reference46 articles.
1. Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain
2. EFFECTS OF MOUSE TUMOR TRANSPLANTATION ON THE NERVOUS SYSTEM
3. Neuroscience: One hundred years of Rita
4. NGF/TrkA Signaling as a Therapeutic Target for Pain
5. Nerve growth factor receptors on PC12 cells: ligand-induced conversion from low- to high-affinity states.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update;Expert Opinion on Therapeutic Patents;2024-04-02
2. Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib;Acta Pharmaceutica Sinica B;2024-02
3. Recent advances in the structural biology of tyrosine kinases;Current Opinion in Structural Biology;2023-10
4. Recent advances in the discovery of tropomyosin receptor kinases TRKs inhibitors: A mini review;European Journal of Medicinal Chemistry;2023-10
5. A Shift in Thinking: Cellular Thermal Shift Assay-Enabled Drug Discovery;ACS Medicinal Chemistry Letters;2023-03-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3